Notably, a genetic variant of the GLP-1 receptor that enhances receptor sensitivity to GLP-1 is more prevalent in East Asians, potentially contributing to the superior glucose-lowering effects observed with these therapies [16, 17]
Last reviewed: May 31, 2026 Last updated: May 31, 2026 Written by: Jay Hastings , CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Here is the timeline of how we moved from trial-and-error to the gold standard of global medicine
Researchers using proper aseptic technique (alcohol swab, needle change between drawing and injection, single-use syringes) report near-zero contamination
Association of Multiple Blood Metals with thyroid function in general adults: a Cross-sectional study